west china medical publishers
Keyword
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Keyword "House-Brackmann" 2 results
  • Sanqi Tongshu Capsule for Acute Idiopathic Facial Paralysis: A Clinical Controlled Trial

    Objective To evaluate the effect of PNS on Idiopathic facial palsy. Methods A total of 86 cases of acute idiopathic facial paralysis were randomly divided into the treatment group (PNS group, 44 cases), and the control group (42 cases). The basis of the two groups included hormone therapy, B vitamins, anti-viral treatment, as well as acupuncture and physical therapy, both in the incidence of 7 days to give the treatment. House-Brackmann facial nerve function classification and evaluation were used to determine clinical efficacy; ENoG line was tested before and after treatment. Results Before H-B classification of facial nerve function, EnoG side of the latency and amplitude in the two groups were comparable. At 28 days after treatment, H-B scores for the treatment group and the control group were (2.33 ± 1.21) and (3.08 ± 1.35), respectively, and the two groups had significant differences (Plt;0.05); ENoG incubation period (2.46 ± 0.34) and amplitude (189 ± 67) of the treatment group were more than those of the control group; the incubation period (3.37 ± 0.49) and amplitude (131 ± 52) improved, and there were significant differences between the two groups (Plt;0.05). Comparison of efficacy of the two groups showed the total effective rate: 95.45% in the treatment group, 80.95% in the control group, and the efficacy of the treatment group was better than that of the control group (Plt;0.05). Conclusion Sanqi tongshu, B vitamins, anti-virus, such as the acupuncture and physical therapy for the treatment of acute idiopathic facial paralysis have significant effect.

    Release date:2016-08-25 02:51 Export PDF Favorites Scan
  • 阿昔洛韦治疗特发性周围性面瘫

    目的 探讨阿昔洛韦抗病毒治疗对特发性周围性面瘫患者的治疗作用。 方法 通过病例对照研究对2010年1月-2012年6月入院的特发性面瘫患者78例,使用随机表法随机分为阿昔洛韦治疗组和对照组,每组39例。治疗2周,对两组患者治疗前、2周、4周及8周后使用House-Brackmann面神经分级标准进行评定面瘫恢复情况。 结果 两组患者面瘫2 周缓解率分别为51.3%和48.7%;8周后面瘫恢复率分别为84.6%和87.2%,差异均无统计学意义(P>0.05)。 结论 特发性面瘫患者加用抗病毒治疗疗效未见明显提高,不推荐常规使用抗病毒治疗。

    Release date:2016-08-26 02:09 Export PDF Favorites Scan
1 pages Previous 1 Next

Format

Content